Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
or

Cytosorbents Cor (CTSO)

Cytosorbents Cor (CTSO)
1.0500 x 1 1.1400 x 7
Post-market by (Cboe BZX)
1.0700 -0.0300 (-2.73%) 04/23/25 [NASDAQ]
1.0500 x 1 1.1400 x 7
Post-market 1.0700 unch (unch) 16:00 ET
Quote Overview for Wed, Apr 23rd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.0604
Day High
1.1000
Open 1.1000
Previous Close 1.1000 1.1000
Volume 16,176 16,176
Avg Vol 68,669 68,669
Stochastic %K 74.60% 74.60%
Weighted Alpha +0.98 +0.98
5-Day Change +0.0600 (+5.94%) +0.0600 (+5.94%)
52-Week Range 0.7000 - 1.6100 0.7000 - 1.6100
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 68,750
  • Shares Outstanding, K 62,500
  • Annual Sales, $ 35,590 K
  • Annual Income, $ -20,720 K
  • EBIT $ -19 M
  • EBITDA $ -17 M
  • 60-Month Beta 1.17
  • Price/Sales 1.91
  • Price/Cash Flow N/A
  • Price/Book 5.37

Options Overview Details

View History
  • Implied Volatility 338.71% ( -217.05%)
  • Historical Volatility 50.74%
  • IV Percentile 43%
  • IV Rank 32.04%
  • IV High 930.92% on 04/26/24
  • IV Low 59.51% on 09/20/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 10
  • Volume Avg (30-Day) 26
  • Put/Call OI Ratio 0.02
  • Today's Open Interest 745
  • Open Int (30-Day) 739

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.08
  • Number of Estimates 2
  • High Estimate -0.08
  • Low Estimate -0.08
  • Prior Year -0.12
  • Growth Rate Est. (year over year) +33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.9300 +15.05%
on 04/09/25
Period Open: 0.9835
1.1400 -6.14%
on 04/21/25
+0.0865 (+8.80%)
since 03/21/25
3-Month
0.9300 +15.05%
on 04/09/25
Period Open: 1.0300
1.6100 -33.54%
on 02/14/25
+0.0400 (+3.88%)
since 01/23/25
52-Week
0.7000 +52.86%
on 07/01/24
Period Open: 0.8790
1.6100 -33.54%
on 02/14/25
+0.1910 (+21.73%)
since 04/23/24

Most Recent Stories

More News
CytoSorbents: Q4 Earnings Snapshot

CytoSorbents: Q4 Earnings Snapshot

CTSO : 1.0700 (-2.73%)
CytoSorbents Postpones Earnings Release to Allow More Time to Complete Annual Audit Following the Passing of Corporate Controller

CTSO : 1.0700 (-2.73%)
CytoSorbents to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

CTSO : 1.0700 (-2.73%)
CytoSorbents Further Strengthens Balance Sheet with Exercise of Previously Announced Series A Right Warrants

CTSO : 1.0700 (-2.73%)
CytoSorbents Strengthens Balance Sheet with Closing of Oversubscribed Rights Offering

CTSO : 1.0700 (-2.73%)
CytoSorbents Expands Global Footprint with Opening of New Regional Sales Subsidiary in Dubai

CTSO : 1.0700 (-2.73%)
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue

CTSO : 1.0700 (-2.73%)
CytoSorbents Rights Offering Begins

CTSO : 1.0700 (-2.73%)
Insider Purchase: Chief Financial Officer of $CTSO (CTSO) Buys 20,000 Shares

PETER J MARIANI, the Chief Financial Officer of $CTSO ($CTSO), bought 20,000 shares of the company on 12-12-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This...

CTSO : 1.0700 (-2.73%)
CytoSorbents Corporation Announces In-Person Investor Meetings at J.P. Morgan Healthcare Conference 2025 in San Francisco

CytoSorbents will host investor meetings in San Francisco during the J.P. Morgan Healthcare Conference from January 13-15, 2025.Quiver AI SummaryCytoSorbents Corporation, a leader in blood purification...

CTSO : 1.0700 (-2.73%)

Business Summary

CytoSorbents Corporation is a therapeutic medical device company. It develops adsorbent polymer technology for applications in the medical field, primarily to provide blood purification for the treatment of acute and chronic health complications associated with blood toxicity. The Company's product...

See More

Key Turning Points

3rd Resistance Point 1.1328
2nd Resistance Point 1.1164
1st Resistance Point 1.0932
Last Price 1.0700
1st Support Level 1.0536
2nd Support Level 1.0372
3rd Support Level 1.0140

See More

52-Week High 1.6100
Fibonacci 61.8% 1.2624
Fibonacci 50% 1.1550
Last Price 1.0700
Fibonacci 38.2% 1.0476
52-Week Low 0.7000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective